spacer
home > white papers > The EC Definition of a Nanomaterial - Potential Measurement Methodologies - NanoSight
WHITE PAPERS
logo_NanoSightb.jpg

NanoSight

phone +44 (0) 1980 676060
email admin@nanosight.com
web http://www.nanosight.com
email NanoSight Ltd, Minton Park, London Road, Amesbury, Wiltshire SP4 7RT

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.

spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

International Research Coalition Verifies Safe Surgical Access to the Central Core of the Human Cochlea for the Very First Time

SHEFFIELD, UK, 8 November 2022: An international team of surgeons and scientists has, for the first time, validated safe surgical access to the central core of the human cochlea in a study funded by Rinri Therapeutics, a biotechnology company developing regenerative cell therapies for sensorineural hearing loss (SNHL).
More info >>


White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement